TY - JOUR
T1 - Pharmacists’ perspectives and experience prescribing hormonal contraception in rural and urban New Mexico
AU - Rodriguez, Maria I.
AU - Herman, Alexandra M.
AU - Espey, Eve
AU - Hersh, Alyssa R.
AU - Bachyrycz, Amy M.
N1 - Funding Information:
Funding: Arnold Ventures . Research Electronic Data Capture, through the Oregon Health & Science University , was used for this study; as such, this research was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UL1TR0002369.
Funding Information:
Disclosure: Maria I. Rodriguez’s institution has received research funding from Arnold Ventures , National Institutes of Health, World Health Organization (WHO), Robert Wood Johnson Foundation , and Merck for projects on which she is primary investigator. She has served as a contraceptive trainer for Bayer, Merck, and WHO. The authors declare no other relevant conflicts of interest or financial relationships.
Publisher Copyright:
© 2021 American Pharmacists Association®
PY - 2021/3/1
Y1 - 2021/3/1
N2 - Background: Pharmacist prescription of contraception is becoming increasingly common in the United States (US). Limited information exists on whether this is improving access to contraception in underserved areas, including rural America. Objective: We sought to determine whether there were differences by rural location in pharmacists’ willingness to prescribe hormonal contraception and perceived barriers to doing so. Methods: We conducted a cross-sectional survey of pharmacists eligible to prescribe hormonal contraception in New Mexico in March and May 2020. The survey consisted of demographic data, pharmacists’ experience prescribing hormonal contraception, and questions regarding perceived barriers to pharmacist-prescribed hormonal contraception. Descriptive statistics assessed differences in survey responses between rural and urban pharmacists. We used multivariable logistic regression to estimate the association between rural practice and prescribing hormonal contraception. Results: Our sampling frame consisted of 822 licensed pharmacists. We received 256 responses, for a response rate of 31.1%. We found that rural pharmacists were as likely as their urban counterparts to prescribe hormonal contraception (adjusted odds ratio 1.22 [95% CI 0.56–2.68], P = 0.50). Five main barriers included a need for additional training, reimbursement for services, liability concerns, corporate policies, and shortage of staff. No difference in barriers were identified by rural location or staff role. Conclusion: Pharmacy access has the potential to improve access to contraception across New Mexico, including underserved rural areas.
AB - Background: Pharmacist prescription of contraception is becoming increasingly common in the United States (US). Limited information exists on whether this is improving access to contraception in underserved areas, including rural America. Objective: We sought to determine whether there were differences by rural location in pharmacists’ willingness to prescribe hormonal contraception and perceived barriers to doing so. Methods: We conducted a cross-sectional survey of pharmacists eligible to prescribe hormonal contraception in New Mexico in March and May 2020. The survey consisted of demographic data, pharmacists’ experience prescribing hormonal contraception, and questions regarding perceived barriers to pharmacist-prescribed hormonal contraception. Descriptive statistics assessed differences in survey responses between rural and urban pharmacists. We used multivariable logistic regression to estimate the association between rural practice and prescribing hormonal contraception. Results: Our sampling frame consisted of 822 licensed pharmacists. We received 256 responses, for a response rate of 31.1%. We found that rural pharmacists were as likely as their urban counterparts to prescribe hormonal contraception (adjusted odds ratio 1.22 [95% CI 0.56–2.68], P = 0.50). Five main barriers included a need for additional training, reimbursement for services, liability concerns, corporate policies, and shortage of staff. No difference in barriers were identified by rural location or staff role. Conclusion: Pharmacy access has the potential to improve access to contraception across New Mexico, including underserved rural areas.
UR - http://www.scopus.com/inward/record.url?scp=85099587837&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85099587837&partnerID=8YFLogxK
U2 - 10.1016/j.japh.2020.11.012
DO - 10.1016/j.japh.2020.11.012
M3 - Article
C2 - 33446459
AN - SCOPUS:85099587837
SN - 1544-3191
VL - 61
SP - e140-e144
JO - Journal of the American Pharmaceutical Association. American Pharmaceutical Association
JF - Journal of the American Pharmaceutical Association. American Pharmaceutical Association
IS - 2
ER -